Publications Prevalence and prognostic effect of high tumor mutation burden (TMB-H) across multiple less common solid cancers using a real-world dataset September 27, 2019 Backenroth D, Shao C, Li G, Huang L,Pruitt SK, Castellanos EH, Frampton GM, Carson KR, Snow T, Singal G, Fabrizio D, Alexander BM, Jin FJ, Zhou W. ESMO Annual Congress. . https://www.sciencedirect.com/science/article/pii/S0923753419600062 Authors:Backenroth D, Shao C, Li G, Huang L,Pruitt SK, Castellanos EH, Frampton GM, Carson KR, Snow T, Singal G, Fabrizio D, Alexander BM, Jin FJ, Zhou W Sources:ESMO Annual Congress Read the research SharePosted inTumor agnosticClinical development More publicationsNovember 2025A pan-tumor and pan-country approach to LLM-based extraction of systemic therapies from the electronic health recordJune 2025Impact of renal function eligibility criteria in clinical trials and real world survival outcomes among patients with metastatic renal cell carcinomaMay 2025Molecular residual disease (MRD) in solid tumors
November 2025A pan-tumor and pan-country approach to LLM-based extraction of systemic therapies from the electronic health record
June 2025Impact of renal function eligibility criteria in clinical trials and real world survival outcomes among patients with metastatic renal cell carcinoma